Latest News

• share
• favorite_border

World-renowned cardiologist Valentin Fuster, MD, PhD, Director of Mount Sinai Heart and Physician-in-Chief at The Mount Sinai Medical Center, is the recipient of the 2013 Camino Real Award by the Research Institute of North American Studies “Benjamin Franklin” of the University of Alcalá (Instituto Franklin – UAH) in Spain. The award recognizes Dr. Fuster as a prestigious Spaniard whose lifelong professional work has contributed to the positive image and promotion of Spain in North America.

• share
• favorite_border

The Society of Cardiovascular Computed Tomography (SCCT) has honored Valentin Fuster, MD, PhD, Director of Mount Sinai Heart at The Mount Sinai Medical Center, with the 2013 SCCT Arthur S. Agatston Cardiovascular Disease Prevention Award at its SCCT Annual Scientific Meeting in Montréal, Canada, on July 12.

• share
• favorite_border

Partho P. Sengupta, MBBS, MD, DM, FASE, Director of Cardiac Ultrasound Research and Associate Professor of Medicine in Cardiology at The Mount Sinai Medical Center, conducted the first-ever presentation using hologram technology at The American Society of Echocardiography’s (ASE) 2013 24th Annual Scientific Sessions on July 1 in Minneapolis, Minnesota.

• share
• favorite_border

The Fondation Leducq in Paris, France, dedicated to improving human health through international efforts to combat cardiovascular disease, awarded a $6 million grant award to a new global research network of cardiovascular scientists which includes three researchers from the Cardiovascular Research Center at Icahn School of Medicine at Mount Sinai.

• share
• favorite_border

The Mount Sinai Medical Center is the first medical center in New York City to offer the newly FDA approved HeartMate II® Pocket Controller™ to help its advanced heart failure patients maintain more active lifestyles. This latest generation controller for the HeartMate II left ventricular assist device (LVAD) is a new small, light-weight, patient-friendly external controller about the size of a smart phone that easily fits in a patient’s front pocket and powers their heart to pump.

• share
• favorite_border

The American Heart Association (AHA) has awarded world-renowned cardiologist Dr. Valentin Fuster, MD, PhD, Director of Mount Sinai Heart at The Mount Sinai Medical Center, its prominent American Heart Association/American Stroke Association Ron Haddock International Impact Award.

• share
• favorite_border

ADHD drug helps improve brain functional connectivity in cocaine addiction.

• share
• favorite_border

Mount Sinai Researchers present new data at ENDO 2013, The Endocrine Society’s Annual Meeting & Expo June 15-18 in San Francisco. Mount Sinai experts also demonstrate new research on prostate cancer bone metastases; identify new molecules that stimulate thyroid receptors; reveal the under diagnosis of primary aldosteronism; and show how thyroid autoimmunity may be triggered by endoplasmic reticulum stress

• share
• favorite_border

Study is first step towards generating patient-specific blood products for cell-replacement therapy.

• share
• favorite_border

Multiple drug classes commonly prescribed for common medical conditions are capable of influencing the onset and progression of Alzheimer’s disease.

• share
• favorite_border

First study to describe clinical presentation of Phelan-McDermid Syndrome will help guide future research and clinical care.

• share
• favorite_border

A novel gene variant found in human and animal tissue may be a promising treatment for cancer, including breast and brain cancer.

• share
• favorite_border

New research from the Icahn School of Medicine at Mount Sinai, published in the journal Cell Stem Cell today, suggests that it may one day become possible to regenerate a liver using cell therapy in patients with liver disease. Investigators discovered that a human embryonic stem cell can be differentiated into a previously unknown liver progenitor cell, an early offspring of a stem cell, and produce mature and functional liver cells.

• share
• favorite_border

MRI may be an effective way to diagnose mental illnesses such as bipolar disorder, according to experts from the Icahn School of Medicine at Mount Sinai.

• share
• favorite_border

Mount Sinai researchers will present several landmark studies at the 2013 ASCO meeting, including data on the likelihood of spousal human papillomavirus (HPV) oral infection, new gene signatures in melanoma, and issues with high readmission rates after cancer surgery.

• share
• favorite_border

Two mutations central to the development of infantile myofibromatosis (IM)—a disorder characterized by multiple tumors involving the skin, bone, and soft tissue—may provide new therapeutic targets, according to researchers from the Icahn School of Medicine at Mount Sinai.

• share
• favorite_border

Drug associated with rapid antidepressant effect in largest clinical trial to-date.

• share
• favorite_border

Mount Sinai researcher estimates that lead exposure could cause mental retardation in 6 in 1,000 children living near the sites.

• share
• favorite_border

Jeffrey Mechanick, MD, Director of Metabolic Support in the Division of Endocrinology, Diabetes and Bone Disease and Clinical Professor of Medicine at The Mount Sinai Medical Center, was announced as the new President of the American Academy of Clinical Endocrinologists (AACE) during the 22nd Annual Scientific & Clinical Congress in Phoenix on May 4.

• share
• favorite_border

Toxic waste sites with elevated levels of lead and chromium cause a high number of “healthy years of life lost” in individuals living near 373 sites located in India, Philippines and Indonesia, according to a study by a Mount Sinai researcher published online today in Environmental Health Perspectives. The study leader, Kevin Chatham-Stephens, MD, Pediatric Environmental Health Fellow at the Icahn School of Medicine at Mount Sinai, presented the findings today at the Pediatric Academic Societies (PAS) annual meeting in Washington, DC.

• share
• favorite_border

Research Identifies Potential Therapeutic Targets for Late Onset Alzheimer’s Disease (LOAD) By Revealing a Network of Genes Involved in the Inflammatory Response.

• share
• favorite_border

Skin cancer is the most common form of cancer in the United States, with one in five Americans developing it over the course of their lives. It’s also one of the most preventable types of cancers. Since May is Skin Cancer Awareness Month and Melanoma Monday is May 6th, Mount Sinai experts are sharing tips on prevention.

• share
• favorite_border

Findings pinpoint 14 genetic targets in humans that may provide insight for the treatment of cardiovascular disease.

• share
• favorite_border

Mount Sinai Researchers Present Targets, Treatments for Prostate, Colon, and Ovarian Cancer at the American Association for Cancer Research Annual Meeting

• share
• favorite_border

Preventive Measures, Genetic Risks, New Diagnostic Tools Needed to Identify Effects of Traumatic Brain Injury in Athletes, Soldiers

• share
• favorite_border

Considerable opportunity exists to improve interventions and outcomes of traumatic brain injury (TBI) in older adults, according to three studies published in the recent online issue of NeuroRehabilitation by researchers from the Icahn School of Medicine at Mount Sinai.

• share
• favorite_border

The latest report from the US Centers for Disease Control and Prevention estimates that one out of 50 school-aged children has an autism spectrum disorder (ASD). Researchers have made great strides in identifying potential causes and treatments for ASD, and experts from the Seaver Autism Center at Mount Sinai are available to educate families on what these advancements are and what signs and symptoms they should watch out for, in honor of Autism Awareness Month.

• share
• favorite_border

Sam Gandy, MD, PhD, of the Icahn School of Medicine at Mount Sinai is leading an international team of researchers working to reprogram skin cells into brain cells to gain a better understanding of Alzheimer’s disease (AD)

• share
• favorite_border

Doses of medicine 100,000 times smaller than the diameter of a human hair prevent the tissue damage associated with atherosclerosis and other chronic diseases in mice.

• share
• favorite_border

To develop new treatment options for patients with SD who failed available options, a Mount Sinai team is examining the central mechanisms of action of a novel oral medication, sodium oxybate, which is FDA-approved for narcolepsy. Anecdotally, about 20 percent of SD patients have positive effects of alcohol on their voice symptoms.

• share
• favorite_border

Drugs taken together do not reduce risk of relapse but appear to prevent development of new lesions.

• share
• favorite_border

Medicare patients who enrolled in hospice received better care at a significantly lower cost to the government than those who did not use the Medicare hospice benefit. The data indicate that annual savings to Medicare could amount to $2.4 million to $6.4 million, if 1,000 additional Medicare beneficiaries chose to enroll in hospice 53-105 days before death, or 15-30 days prior to death.

• share
• favorite_border

Program aims to attract sophomores in fields as diverse as biophysics and computer science, to global health and the arts.

• share
• favorite_border

Binge drinking causes insulin resistance, which increases the risk of Type 2 diabetes, according to the results of an animal study led by researchers at the Diabetes Obesity and Metabolism Institute at the Icahn School of Medicine at Mount Sinai. The authors further discovered that alcohol disrupts insulin-receptor signaling by causing inflammation in the hypothalamus area of the brain.

• share
• favorite_border

Mount Sinai has officially opened a new center to treat and research tic and obsessive-compulsive disorders (OCD) in individuals of all ages. The opening coincides with a significant revision in the psychiatry field’s manual of mental disorders, which will now recognize OCD with its own category, rather than classifying it as an anxiety disorder.

• share
• favorite_border

Corita Grudzen, MD, MSHS, Assistant Professor of Emergency Medicine and Geriatrics and Palliative Medicine at the Icahn School of Medicine at Mount Sinai has been selected as one of 10 inaugural members of The Practice Change Leaders for Aging and Health program for experts in geriatric care.

• share
• favorite_border

According to researchers at the Icahn School of Medicine at Mount Sinai, the flu knows how much time it has to multiply, infect other cells, and spread to another human being. If it leaves a cell too soon, the virus is too weak. If it leaves too late, the immune system has time to kill the virus.

• share
• favorite_border

A team of scientists has developed a playbook for ending the devastating impact of fibrotic diseases of the liver, lung, kidney, and other organs, which are responsible for as many as 45 percent of all deaths in the industrialized world.

• share
• favorite_border

Nearly a third of children diagnosed with food allergies who participated in a recent study are bullied, according to researchers at the Icahn School of Medicine at Mount Sinai. Almost eight percent of children in the U.S. are allergic to foods such as peanuts, tree-nuts, milk, eggs, and shellfish.

• share
• favorite_border

Autism sequencing consortium discovers six new drug targets through large-scale studies.

• share
• favorite_border

A new oral agent under review by the U.S. Food and Drug Administration (FDA) is safe and effective in treating relapsed and treatment-resistant multiple myeloma, according to a multicenter, Phase II study presented by Mount Sinai School of Medicine researchers at the American Society of Hematology (ASH) Annual Meeting.

• share
• favorite_border

Health care policy changes needed to support patients and their hospice providers.

• share
• favorite_border

Reduced production of myelin, a type of protective nerve fiber that is lost in diseases like multiple sclerosis, may also play a role in the development of mental illness, according to researchers at the Graduate School of Biomedical Sciences at Mount Sinai School of Medicine.

• share
• favorite_border

Previously discarded, human-specific “junk” DNA represents untapped resource in the study of diseases like Alzheimer’s and autism.

• share
• favorite_border

Experts also present research on Impact of Education on Drug Adherence, Diabetes on Heart Disease and 3D Ultrasound Technology on Disease Detection.

• share
• favorite_border

Study provides the first evidence suggesting that the empathy deficits in patients with brain damage to the anterior insular cortex are surprisingly similar to the empathy deficits found in several psychiatric diseases, including autism spectrum disorders, borderline personality disorder, schizophrenia, and conduct disorders, suggesting potentially common neural deficits in those psychiatric populations.

• share
• favorite_border

The Brain Injury Research Center of Mount Sinai has received two prestigious grants totaling $6.65 million to fund research on traumatic brain injury (TBI) over the next five years.

• share
• favorite_border

New research from Mount Sinai School of Medicine sheds light on how overeating can cause a malfunction in brain insulin signaling, and lead to obesity and diabetes. Christoph Buettner, MD, PhD, Associate Professor of Medicine (Endocrinology, Diabetes and Bone Disease) and his research team found that overeating impairs the ability of brain insulin to suppress the breakdown of fat in adipose tissue.

• share
• favorite_border

Andrew Fyfe Stewart, MD, a renowned expert in endocrinology and diabetes research, will join The Mount Sinai Medical Center as Director of the Diabetes, Obesity, and Metabolism Institute on November 1. Through interdisciplinary translational research collaborations, the Metabolism Institute focuses on understanding the basic mechanisms involved in metabolic diseases, mainly diabetes and obesity, and aims to develop and promote prevention and treatment programs for those conditions.

• share
• favorite_border

Researchers from Mount Sinai School of Medicine are presenting important discoveries on the involvement of the immune system and dopamine cells in the onset of depression at Neuroscience 2012, the Society for Neuroscience’s 42nd annual meeting on October 13 -17 in New Orleans, and are available for interviews.